OA08242A - Imidazoquinoline antithrombogenic cardiotonic agents - Google Patents

Imidazoquinoline antithrombogenic cardiotonic agents

Info

Publication number
OA08242A
OA08242A OA58845A OA58845A OA08242A OA 08242 A OA08242 A OA 08242A OA 58845 A OA58845 A OA 58845A OA 58845 A OA58845 A OA 58845A OA 08242 A OA08242 A OA 08242A
Authority
OA
OAPI
Prior art keywords
imidazoquinoline
antithrombogenic
cardiotonic agents
cardiotonic
agents
Prior art date
Application number
OA58845A
Other languages
English (en)
Inventor
Nicholas A Meanwell
John J Wright
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA08242A publication Critical patent/OA08242A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA58845A 1985-04-25 1986-04-25 Imidazoquinoline antithrombogenic cardiotonic agents OA08242A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72686985A 1985-04-25 1985-04-25
US06/832,212 US4668686A (en) 1985-04-25 1986-02-26 Imidazoquinoline antithrombrogenic cardiotonic agents

Publications (1)

Publication Number Publication Date
OA08242A true OA08242A (en) 1987-10-30

Family

ID=27111398

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58845A OA08242A (en) 1985-04-25 1986-04-25 Imidazoquinoline antithrombogenic cardiotonic agents

Country Status (32)

Country Link
US (1) US4668686A (sv)
KR (1) KR940000828B1 (sv)
CN (1) CN1016175B (sv)
AT (1) AT390257B (sv)
AU (1) AU592983B2 (sv)
BE (1) BE904671A (sv)
CA (1) CA1298836C (sv)
CH (1) CH675722A5 (sv)
CY (1) CY1641A (sv)
DE (1) DE3614132A1 (sv)
DK (3) DK164868C (sv)
EG (1) EG18104A (sv)
ES (3) ES8708229A1 (sv)
FI (1) FI83316C (sv)
FR (1) FR2581065B1 (sv)
GB (1) GB2174987B (sv)
GR (1) GR861086B (sv)
HK (1) HK64492A (sv)
HU (1) HU195813B (sv)
IL (1) IL78581A0 (sv)
IT (1) IT1215651B (sv)
LU (1) LU86406A1 (sv)
MY (1) MY102086A (sv)
NL (1) NL8601053A (sv)
NO (1) NO163406C (sv)
NZ (1) NZ215885A (sv)
OA (1) OA08242A (sv)
PT (1) PT82460B (sv)
SE (1) SE461468B (sv)
SG (1) SG29092G (sv)
SU (3) SU1450746A3 (sv)
YU (1) YU46054B (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4743607A (en) * 1987-05-29 1988-05-10 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic imidazolones
US4803210A (en) * 1987-05-29 1989-02-07 Merrell Dow Pharmaceuticals Inc. Cardiotonic tricyclic oxazolones
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
DE4035854C2 (de) * 1990-11-10 1996-10-02 Daimler Benz Ag Vorrichtung zum Fangen und Ableiten des von einem Fahrzeugrad hochgeschleuderten Spritzwassers
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
KR101106812B1 (ko) 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
JP5043435B2 (ja) 2003-10-03 2012-10-10 スリーエム イノベイティブ プロパティズ カンパニー アルコキシ置換イミダゾキノリン
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
JP2007511535A (ja) * 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ,インコーポレイテッド ピラゾロピリジン−1,4−ジアミン、およびそのアナログ
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US8227603B2 (en) 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
ES2439590T3 (es) 2006-08-02 2014-01-23 Cytokinetics, Inc. Ciertas entidades químicas, composiciones y métodos
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
WO2008121333A1 (en) 2007-03-30 2008-10-09 Cytokinetics, Incorporated Certain chemical entities, compositions and methods
CA2849213A1 (en) 2011-07-13 2013-01-17 Cytokinetics, Inc. Combination of riluzole and ck-2017357 for treating als

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Also Published As

Publication number Publication date
HUT42089A (en) 1987-06-29
GB2174987A (en) 1986-11-19
LU86406A1 (fr) 1986-11-05
NO163406B (no) 1990-02-12
DK165249B (da) 1992-10-26
DK80291A (da) 1991-04-30
ATA112186A (de) 1989-09-15
CN86102747A (zh) 1987-02-04
FI861684A0 (fi) 1986-04-22
GB2174987B (en) 1989-08-02
YU46054B (sh) 1992-12-21
NL8601053A (nl) 1986-11-17
IL78581A0 (en) 1986-08-31
YU116787A (en) 1988-04-30
FR2581065A1 (fr) 1986-10-31
SU1450746A3 (ru) 1989-01-07
KR860008177A (ko) 1986-11-12
DK165248C (da) 1993-03-22
DK81091A (da) 1991-05-01
HK64492A (en) 1992-09-04
ES8802521A1 (es) 1988-07-16
IT8620206A0 (it) 1986-04-24
PT82460A (en) 1986-05-01
SU1560056A3 (ru) 1990-04-23
AT390257B (de) 1990-04-10
DK190986A (da) 1986-10-26
FI861684A (fi) 1986-10-26
FR2581065B1 (fr) 1990-02-02
BE904671A (fr) 1986-10-24
FI83316C (sv) 1991-06-25
DK80291D0 (da) 1991-04-30
SU1470192A3 (ru) 1989-03-30
DK165248B (da) 1992-10-26
NO163406C (no) 1990-05-23
ES557552A0 (es) 1988-07-16
IT1215651B (it) 1990-02-22
DK165249C (da) 1993-03-22
KR940000828B1 (ko) 1994-02-02
AU592983B2 (en) 1990-02-01
CN1016175B (zh) 1992-04-08
FI83316B (fi) 1991-03-15
SE8601907D0 (sv) 1986-04-24
NO861617L (no) 1986-10-27
ES8801829A1 (es) 1988-02-16
ES557551A0 (es) 1988-02-16
NZ215885A (en) 1989-04-26
EG18104A (en) 1992-09-30
ES8708229A1 (es) 1987-10-01
CY1641A (en) 1992-11-06
AU5641386A (en) 1986-10-30
ES554336A0 (es) 1987-10-01
CH675722A5 (sv) 1990-10-31
MY102086A (en) 1992-03-31
SG29092G (en) 1992-05-15
CA1298836C (en) 1992-04-14
HU195813B (en) 1988-07-28
DK81091D0 (da) 1991-05-01
DK164868C (da) 1993-01-11
DK190986D0 (da) 1986-04-24
PT82460B (pt) 1988-11-30
SE461468B (sv) 1990-02-19
SE8601907L (sv) 1986-10-26
DK164868B (da) 1992-08-31
GR861086B (en) 1986-09-01
US4668686A (en) 1987-05-26
DE3614132A1 (de) 1986-11-27
GB8610037D0 (en) 1986-05-29

Similar Documents

Publication Publication Date Title
OA08242A (en) Imidazoquinoline antithrombogenic cardiotonic agents
GB8518300D0 (en) Contrast agent
GB8522535D0 (en) Contrast agent
GB8626240D0 (en) Antimicrobial agents
GB8611895D0 (en) Antistatic agents
AR243887A1 (es) Procedimiento para la preparacion de piridilcarbonil-tiazolonas cardiotonicas.
ZA863029B (en) Imidazoquinoline antithrombogenic cardiotonic agents
ZA865426B (en) Antihypertensive agents
ZA863645B (en) Yield-promoting agents
GB8513358D0 (en) Formulation
GB8525013D0 (en) Antidiarrhoel agents
GB8618196D0 (en) Antihypertensive agents
PH23182A (en) Cardiotonic alkanoylthiazolones
PH23175A (en) Cardiotonic aroylthiazolones
GR861916B (en) Antihypertensive agents
EG17810A (en) Antistatic agents
IE861087L (en) Imidazoquinoline cardiotonic agent
IE850585L (en) Benzisothiazoles-fungicidal agents
CA54825S (en) Saladware caddy
CA54285S (en) Footstool
GB8517710D0 (en) Antimicrobial agents
ZA867749B (en) Cardiotonic aroylthiazolones
IL80301A0 (en) Cardiotonic aroylthiazolones
YU119085A (en) Homogenizer
HUT40500A (en) Air-state homogenizer